Common Contracts
9 similar Placement Agency Agreement contracts by GeoVax Labs, Inc., Aastrom Biosciences Inc, Emisphere Technologies Inc, others
Neonode Inc. 1,808,000 Shares of Common Stock, par value $0.001 per share PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • October 21st, 2021 • Neonode Inc. • Electronic components, nec • New York
Neonode Inc, a Delaware corporation (the “Company”), proposes to issue and sell 1,808,000 shares (the “Offered Shares” or “Offered Securities”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), to certain investors (each, an “Investor” and collectively, the “Investors”). The Company desires to engage you as its placement agent (together, the “Placement Agent”) in connection with such issuance and sale. The Offered Securities are more fully described in the Registration Statement (as hereinafter defined).
GEOVAX LABS, INC. Units Representing up to $10 Million (________ Units), Each Consisting of One Share of Common Stock and One Five-Year Warrant to Purchase One (1) Additional Share of Common Stock PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • March 4th, 2011 • GeoVax Labs, Inc. • Services-commercial physical & biological research • Delaware
GeoVax Labs, Inc., a Delaware corporation (the “Company”) proposes to issue and sell units (the “Units”), with each Unit consisting of one share of common stock (each, a “Share”), par value $0.001 per share (the “Common Stock”) and one five-year warrant to purchase one (1) additional share of Common Stock, a form of which is attached hereto as Exhibit A (each, a “Warrant”) to certain investors that are “accredited investors” within the meaning of Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended (the “Act”) or “qualified institutional buyers” within the meaning of Rule 144A (collectively, the “Investors”), or are otherwise approved by the Company to invest. The Company desires to engage Gilford Securities, Incorporated (“Gilford”) as the placement agent ( the “Placement Agent”) in connection with such issuance and sale of the Units (the “Offering”). The Units, Shares and Warrants are more fully described in the Registration Statement (as hereinafter d
GEOVAX LABS, INC. From Units Representing $5 Million (________ Units) to Units Representing $10 Million (________ Units), Each Consisting of One Share of Common Stock and One Five-Year Warrant to Purchase One (1) Additional Share of Common Stock...Placement Agency Agreement • November 8th, 2010 • GeoVax Labs, Inc. • Services-commercial physical & biological research • Delaware
GeoVax Labs, Inc., a Delaware corporation (the “Company”) proposes to issue and sell units (the “Units”), with each Unit consisting of one share of common stock (each, a “Share”), par value $0.001 per share (the “Common Stock”) and one five-year warrant to purchase one (1) additional share of Common Stock, a form of which is attached hereto as Exhibit A (each, a “Warrant”) to certain investors that are “accredited investors” within the meaning of Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended (the “Act”) or “qualified institutional buyers” within the meaning of Rule 144A (collectively, the “Investors”), or are otherwise approved by the Company to invest. The Company desires to engage Global Hunter Securities LLC (“GHS”) and Gilford Securities, Incorporated (“Gilford”) as the placement agents (collectively, the “Placement Agents”), with GHS acting as the lead Placement Agent, in connection with such issuance and sale of the Units (the “Offering”). T
GEOVAX LABS, INC. From Units Representing $5 Million (________ Units) to Units Representing $10 Million (________ Units), Each Consisting of One Share of Common Stock and One Five-Year Warrant to Purchase One (1) Additional Share of Common Stock...Placement Agency Agreement • August 30th, 2010 • GeoVax Labs, Inc. • Services-commercial physical & biological research • Delaware
GeoVax Labs, Inc., a Delaware corporation (the “Company”) proposes to issue and sell units (the “Units”), with each Unit consisting of one share of common stock (each, a “Share”), par value $0.001 per share (the “Common Stock”) and one five-year warrant to purchase one (1) additional share of Common Stock, a form of which is attached hereto as Exhibit A (each, a “Warrant”) to certain investors that are “accredited investors” within the meaning of Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended (the “Act”) or “qualified institutional buyers” within the meaning of Rule 144A (collectively, the “Investors”), or are otherwise approved by the Company to invest. The Company desires to engage Global Hunter Securities LLC (“GHS”) and Gilford Securities, Incorporated (“Gilford”) as the placement agents (collectively, the “Placement Agents”), with GHS acting as the lead Placement Agent, in connection with such issuance and sale of the Units (the “Offering”). T
Far East Energy Corporation 105,515,300 Shares of Common Stock, par value $0.001 per share PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • August 20th, 2010 • Far East Energy Corp • Crude petroleum & natural gas • New York
GEOVAX LABS, INC. From Units Representing $5 Million (________ Units) to Units Representing $35 Million (________ Units), Each Consisting of One Share of Common Stock and One Five-Year Warrant to Purchase one (1) Additional Share of Common Stock...Placement Agency Agreement • June 25th, 2010 • GeoVax Labs, Inc. • Services-commercial physical & biological research • Delaware
GeoVax Labs, Inc., a Delaware corporation (the “Company”) proposes to issue and sell units (the “Company Units”), with each Company Unit consisting of one share of common stock (each, a “Company Share”), par value $0.001 per share (the “Common Stock”) and one five-year warrant to purchase one (1) additional share of Common Stock, a form of which is attached hereto as Exhibit A (each, a “Company Warrant”) to certain investors that are “accredited investors” within the meaning of Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended (the “Act”) or “qualified institutional buyers” within the meaning of Rule 144A (collectively, the “Investors”). In addition, the Company together with Emory University (the “Selling Stockholder”) propose to issue and sell units (the “Selling Stockholder Units,” and together with the Company Units, the “Units”), with each Selling Stockholder Unit consisting of one share of Common Stock held by the Selling Stockholder (each, a “S
From Units Representing $5 Million (________ Units) to Units Representing $35 Million (________ Units), Each Consisting of One Share of Common Stock and One Five-Year Warrant to Purchase 0.20 Additional Shares of Common Stock PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • May 24th, 2010 • GeoVax Labs, Inc. • Services-commercial physical & biological research • Delaware
GeoVax Labs, Inc., a Delaware corporation (the “Company”) proposes to issue and sell units (the “Company Units”), with each Company Unit consisting of one share of common stock (each, a “Company Share”), par value $0.001 per share (the “Common Stock”) and one five-year warrant to purchase 0.20 additional shares of Common Stock, a form of which is attached hereto as Exhibit A (each, a “Company Warrant”) to certain investors that are “accredited investors” within the meaning of Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended (the “Act”) or “qualified institutional buyers” within the meaning of Rule 144A (collectively, the “Investors”). In addition, the Company together with Emory University (the “Selling Stockholder”) propose to issue and sell units (the “Selling Stockholder Units,” and together with the Company Units, the “Units”), with each Selling Stockholder Unit consisting of one share of Common Stock held by the Selling Stockholder (each, a “Sel
AASTROM BIOSCIENCES, INC. 15,943,750 Shares of Common Stock, no par value per share PLACEMENT AGENCY AGREEMENT April 6, 2006Placement Agency Agreement • April 6th, 2006 • Aastrom Biosciences Inc • Services-commercial physical & biological research • New York
Aastrom Biosciences, Inc., a Michigan corporation (the “Company”), proposes to issue and sell 15,943,750 shares (the “Shares”) of common stock, no par value per share (the “Common Stock”), to certain investors (collectively, the “Investors”). The Company desires to engage you as its placement agent (the “Placement Agent”) in connection with such issuance and sale. The Shares are more fully described in the Registration Statement (as hereinafter defined).
EMISPHERE TECHNOLOGIES, INC. PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • May 12th, 2005 • Emisphere Technologies Inc • Pharmaceutical preparations • New York
Emisphere Technologies, Inc. proposes to issue and sell to certain investors an aggregate of up to 4,000,000 units (the “Units”) consisting of 4,000,000 shares (the “Offered Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”) and warrants to purchase 1,500,000 shares of Common Stock (the “Offered Warrants”) in accordance with the terms and conditions set forth in this Placement Agency Agreement (the “Agreement”). The Company desires to engage you as its placement agent (the “Placement Agent”) in connection with such issuance and sale. Each Offered Warrant shall be exercisable to purchase one share of Common Stock at a price of $4.00 for a period of five years following the Closing (as defined in Section 2 below). The Common Stock issuable upon exercise of the Offered Warrants is hereinafter referred to as the “Warrant Shares.” The Offered Shares and Offered Warrants will be immediately separable for trading purposes. The Offered Shares, the Offered Wa
